The natural history of motor neuron disease: Assessing the impact of specialist care

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 1, 2013, Pages 13-19

  Aridegbe, Tomi ^a   Kandler, Rosalind ^b   Walters, Stephen J ^c   Walsh, Theresa ^a   Shaw, Pamela J ^a   McDermott, Christopher J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Amyotrophic lateral sclerosis; Motor neuron disease; Multidisciplinary clinic; Prognosis; Survival

Indexed keywords

RILUZOLE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENERAL NEUROLOGY CLINIC; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; MULTIDISCIPLINARY CLINIC GROUP; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; UNITED KINGDOM;

AGED; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEUROLOGY; PATIENT CARE TEAM; PREVALENCE; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875443994     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/17482968.2012.690419     Document Type: Article

References (24)

1. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007; 369: 2031-41.
2. Shaw PJ. Motor neuron disease. Br Med J. 1999; 318: 1118-21.
3. Oliveira AS, Pereira RD. Amyotrophic lateral sclerosis (ALS): three letters that change the people ' s life. Forever. Arq Neuropsiquiatr. 2009; 67: 750-82.
4. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry. 2003; 74: 1258-61.
5. Wood-Allum C, Shaw PJ. Motor neuron disease: a practical update on diagnosis and management. Clin Med. 2010; 10: 252-8.
6. Chio A, Bottacchi E, Buffa C, Mutani R, Mora G, PARALS. Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities. J Neurol Neurosurg Psychiatry. 2006; 77: 948-50.
7. Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME. The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler. 2009; 10: 324-31.
8. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Lepore V, et al. ALS multidisciplinary clinic and survival. Results from a population based study in southern Italy. J Neurol. 2007; 254: 1107-12.
9. Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, et al. Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology. 2002; 59: 99-103.
10. Mazzini L, Corra T, Zaccala M, Mora G, del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995; 242: 695-8.
11. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999; 53: 1059-63.
12. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve. 2002; 25: 709-14.
13. del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003; 60: 813-9.
14. Paillisse C, Lacomblez L, Dib M, Bensimon G, Garcia-Acosta S, Meininger V. Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6: 37-44.
15. Singer MA, Statland JM, Wolfe GI, Barohn RJ. Primary lateral sclerosis. Muscle Nerve. 2007; 35: 291-302.
16. Ince PG, Evans J, Knopp M, Forster G, Hamdalla HH, Wharton SB, et al. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003; 60: 1252-8.
17. Kim WK, Liu X, Sandner J, Pasmantier M, Andrews J, Rowland LP, et al. Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology. 2009; 73: 1686-92.
18. Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufi t R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence based review). Muscle Nerve. 1999; 22: 1104-11.
19. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol. 2006; 5: 140-7.
20. Czaplinski A, Yen AA, Simpson EP, Appel SH. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? Arch Neurol. 2006; 63: 1139-43.
21. Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luis ML. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J Neurol Sci. 1995; 129 (Suppl): 19-26.
22. Sorenson EJ, Mandrekar J, Crum B, Stevens JC. Effect of referral bias on assessing survival in ALS. Neurology. 2007; 68: 600-2.
23. van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, van der Graaff MM, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005; 65: 1264-7.
24. McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis: the role of psychological factors. Arch Neurol. 1994; 51: 17-23.